CEF30, Epstein-Barr Virus BRLF1 (134-142)

CEF30 is a synthetic HLA-A11-restricted CD8⁺ T-cell epitope derived from Epstein-Barr virus immediate-early protein BRLF1, spanning amino acids 134–142. This peptide is commonly used to evaluate EBV-specific cytotoxic T lymphocyte responses during lytic infection. CEF30 supports antigen presentation analysis, immune monitoring, epitope mapping, T-cell activation studies, and functional cellular immune assays. It is a valuable peptide reagent for investigating antiviral immune control mechanisms, EBV lytic-cycle immunity, HLA-restricted T-cell recognition, and immune-based therapeutic strategies targeting EBV-associated diseases.

Product Name: CEF30, Epstein-Barr Virus BRLF1 (134-142)

Sequence One Letter Code: ATIGTAMYK

Sequence Three Letter Code: H-Ala-Thr-Ile-Gly-Thr-Ala-Met-Tyr-Lys-OH

Chemical Formula:C42H70N10O13S

Molecular Weight: 955.2

Purity: ≥ 95%

Form: Lyophilized

Storage Conditions: - 20 °C

Source / Species: EBV

Conjugation: Unconjugated

Code Nacres: NA.26